Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria
Since the discovery of penicillin, β-lactam antibiotics have commonly been used to treat bacterial infections. Unfortunately, at the same time, pathogens can develop resistance to β-lactam antibiotics such as penicillins, cephalosporins, monobactams, and carbapenems by producing β-lactamases. Theref...
Main Authors: | Song Zhang, Xinyu Liao, Tian Ding, Juhee Ahn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/13/3/260 |
Similar Items
-
Contribution of efflux pump hyperactivity to the resistance to new β-lactam-β-lactamase inhibitor combinations including ceftazidime-avibactam, aztreonam-avibactam, and imipenem-relebactam
by: Sung Pin Tseng, et al.
Published: (2024-12-01) -
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians
by: Luigi Principe, et al.
Published: (2022-04-01) -
Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization
by: Nabeela Farhat, et al.
Published: (2022-10-01) -
Evaluation of Metallo-β-Lactamase Susceptibility Testing in a Physiologic Medium
by: Tomefa E. Asempa, et al.
Published: (2021-12-01) -
A Modified Vancomycin Molecule Confers Potent Inhibitory Efficacy against Resistant Bacteria Mediated by Metallo-β-Lactamases
by: Le Zhai, et al.
Published: (2022-11-01)